Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years

Ítems similars

• The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
  per: Baraliakos, Xenofon, et al.
  Publicat: (2008)
• Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis
  per: Baraliakos, X, et al.
  Publicat: (2005)
• Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
  per: Baraliakos, Xenofon, et al.
  Publicat: (2005)
• Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept
  per: Rudwaleit, M, et al.
  Publicat: (2005)
• Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
  per: Baraliakos, X, et al.
  Publicat: (2007)